International Journal Of Radiation Oncology Biology Physics

杂志介绍

International Journal Of Radiation Oncology Biology Physics杂志介绍

《International Journal Of Radiation Oncology Biology Physics》是一本以English为主的未开放获取国际优秀期刊，中文名称国际放射肿瘤学生物学物理学杂志，本刊主要出版、报道医学-ONCOLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为6.4，最新CiteScore 指数为11。

本刊近期中国学者发表的论文主要有：

• Phenylephrine Alleviates 131I Radiation Damage in Submandibular Gland Through Maintaining Mitochondrial Homeostasis

  Author: Xin Yue Wang, Jing Yu, Fu Yin Zhang, Ke Jian Liu, Bin Xiang

• Predictors of Radiation-Induced Liver Disease in Eastern and Western Patients With Hepatocellular Carcinoma Undergoing Proton Beam Therapy

  Author: Cheng-En Hsieh, Bhanu Prasad Venkatesulu, Ching-Hsin Lee, Sheng-Ping Hung, Pei-Fong Wong, Sathvik Panambur Aithala, Byung Kyu Kim, Arvind Rao, Joseph Tung-Chieh Chang, Ngan-Ming Tsang, Chun-Chieh Wang, Chung-Chi Lee, Chen-Chun Lin, Jeng-Hwei Tseng, Wen-Chi Chou, Yu-Chao Wang, Sunil Krishnan, Ji-Hong Hong

• Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design

  Author: Xiaofei Zhu, Xiaoping Ju, Yangsen Cao, Yuxin Shen, Fei Cao, Shuiwang Qing, Fang Fang, Zhen Jia, Huojun Zhang

• Plasma Epstein-Barr Virus DNA Load After Induction Chemotherapy Predicts Outcome in Locoregionally Advanced Nasopharyngeal Carcinoma

  Author: Cheng-Long Huang, Zheng-Qiang Sun, Rui Guo, Xu Liu, Yan-Ping Mao, Hao Peng, Li Tian, Ai-Hua Lin, Li Li, Jian-Yong Shao, Ying Sun, Jun Ma, Ling-Long Tang

英文介绍

International Journal Of Radiation Oncology Biology Physics杂志英文介绍

International Journal of Radiation Oncology • Biology • Physics (IJROBP), known in the field as the Red Journal, publishes original laboratory and clinical investigations related to radiation oncology, radiation biology, medical physics, and both education and health policy as it relates to the field.

This journal has a particular interest in original contributions of the following types: prospective clinical trials, outcomes research, and large database interrogation. In addition, it seeks reports of high-impact innovations in single or combined modality treatment, tumor sensitization, normal tissue protection (including both precision avoidance and pharmacologic means), brachytherapy, particle irradiation, and cancer imaging. Technical advances related to dosimetry and conformal radiation treatment planning are of interest, as are basic science studies investigating tumor physiology and the molecular biology underlying cancer and normal tissue radiation response.